We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fungus-Associated Bacteriome Associated with C. difficile Infection

By LabMedica International staff writers
Posted on 11 Sep 2019
Clostridioides difficile infection (CDI), the most common etiology of nosocomial infectious diarrhea, is caused by an intestinal dysbiosis that is virtually always attributable to antibiotics. More...
This causes one of the most common hospital-acquired infections in the USA.

There is a growing body of data showing that distinct bacterial and fungal community structures distinguish the dysbiotic state of CDI from antibiotic-associated diarrhea due to other causes. The data suggests that transkingdom interactions between fungal and bacterial species play an important role in nosocomial infections.

A team of scientists collaborating with the University of Arizona (Tucson, AZ, USA) collected diarrheal stools from 49 inpatients (18 of whom tested positive for CDI) under stringent inclusion criteria. C. difficile testing was performed using a commercially available nucleic acid amplification test designed to detect a highly conserved sequence within the tcdA gene. C. difficile positive and negative stool samples were preserved.

Fecal DNA extracts were subject to 16S rRNA gene and ITS2 Illumina tag polymerase chain reaction (PCR) (Illumina, San Diego, CA, USA; www.illumina.com), pooled in equimolar ratios, gel purified, and sequenced on the Illumina MiSeq (16S rRNA libraries) and NextSeq (ITS libraries) platforms. Bacterial (16S rRNA gene) and fungal (ITS) sequences were quality filtered, clustered into operational taxonomic units (OTUs), and normalized using both the USEARCH and QIIME pipelines. The team utilized a tiered sequencing approach to identify enriched bacterial and fungal taxa, using 16S and internal transcribed spacer (ITS) rRNA gene amplicon sequencing, with matched metagenomics and metatranscriptomics performed on a subset of the population.

The scientists reported that distinct bacterial and fungal compositions distinguished CDI-positive and -negative patients, with the greatest differentiation between the cohorts observed based on bacterial metatranscriptomics. Bipartite network analyses demonstrated that Aspergillus and Penicillium taxa shared a strong positive relationship in CDI patients and together formed negative co-occurring relationships with several bacterial taxa, including the Oscillospira, Comamonadaceae, Microbacteriaceae, and Cytophagaceae. The investigators identified new pathways associated with C. difficile infections. Those pathways pointed to still other bacterial species, including Escherichia coli that may contribute to the dysbiosis, or imbalance among bacterial species in the gut, associated with C. difficile.

David B. Stewart, MD, a surgeon and first author of the study, said, “The development of C. difficile infection is apparently influenced both by bacterial pathogens and fungi particular to this disease. Until now, fungi have been understudied and under-appreciated in the gut microbiome.” The study was published on August 28, 2019, in the journal mSphere.

Related Links:
University of Arizona


Gold Member
Automated MALDI-TOF MS System
EXS 3000
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A blood biomarker test offers a clearer prognosis after cardiac arrest (Photo courtesy of Adobe Stock)

Blood Biomarker Improves Early Brain Injury Prognosis After Cardiac Arrest

After a cardiac arrest, many patients remain unconscious for days, leaving doctors and families facing uncertainty about whether meaningful recovery is possible. Current tools to assess brain damage, including... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.